Shares are down nearly 80% in 2025, but Trump signed executive order to reclassify marijuana.
Wall Street still sees triple-digit upside in this high-risk biotech bet.
Down 75% from all-time highs, SLMT is a crypto stock that is part of a rapidly expanding market, making it a high-risk, high-reward buy right now.
Wall Street likes Nebius’s AI scale story, but investors are paying upfront for growth that still needs to prove durable.
Microsoft is set to underperform markets for the second consecutive year. Dan Ives of Wedbush, meanwhile, sees it as a “compelling” buy and predicts nearly 30% upside next year.
Reports have emerged that Alibaba could put in an order for the company's MI308 GPUs.
Trump’s call for health insurers to cut premiums adds political pressure to an already challenged sector, raising fresh questions about UnitedHealth’s pricing power, margins, and stock outlook heading...
Super Micro Computer delivered disappointing quarterly results on Nov. 4. SMCI stock has tanked, as investors lost faith in this AI server company. However, large, unusual call options activity in SMCI...
Chipotle added new protein-rich menu items starting on Tuesday, Dec. 23.
Cathie Wood trimmed DraftKings, but the move looks more like portfolio rebalancing than a verdict on the company’s long-term growth.
